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Of the few known central nervous system virus infections of man 
with an immunology that can be studied experimentally in animals, 
St. Louis encephalitis in mice lends itself most readily to quantitative 
analysis.  This virus infection, unlike poliomyelitis, can be studied in 
selectively bred mice which can be used in large numbers and in which 
the majority of disturbing variables can be eliminated or controlled. 
Already the pathogenesis of the infection ~/a the nasal passages has 
been studied both in mice of high inborn susceptibility  (1)  and in 
closely related mice of high inborn resistance (2).  The former suc- 
cumb to an overwhelming  infection of the brain; the latter remain well 
in spite of small, local foci in the brain.  The differences in response 
of these innately susceptible and resistant mice appear to rest largely 
in a difference in the brain tissue itself, no other organ or tissue, in- 
eluding  the  blood,  being  concerned.  Regarding  this  property  of 
brain tissue as the significant factor in inherent resistance, we pro- 
ceeded to  analyze acquired resistance,  especially that  acquired re- 
sistance  developed  through  exposure  to  the  specific  agent.  The 
present studies describe the immunity of mice following subcutaneous 
or  intraperitoneal  vaccination with  virulent  St.  Louis  encephalitis 
virus. 
Materials 
St. Louis virus, strain 3, was passed as routine from brain to brain of susceptible 
mice.  When required for tests,  the virus-containing brain was removed from a 
prostrate susceptible mouse 4 to 5 days following an intracerebral injection.  The 
brain, weighing approximately 0.4 gin., was triturated  in a  mortar, diluted with 
3.6 cc. of hormone broth, pH 7.4, to make an approximately 10 per cent suspension, 
and centrifuged at 1,000 mP.K. for 5 minutes.  The supernatant of the 10 per cent 
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suspension  was  removed and  further  diluted  in  a  tenfold  series.  Upon intra- 
cerebral injection, 0.03 cc. of the 10  -~ dilution was fatal to 50 per cent or more of 
tested mice, hence 3 x 10  -9 cc. were taken as the intracerebral titre of virus under 
these  conditions.  The  brain  is  said  to  contain,  therefore,  approximately  10 ~ 
intracerebral lethal doses of virus.  Similarly, upon nasal instillation, 0.03 cc. of 
the 10  -4 dilution was fatal to 50 per cent or more of tested mice, hence 3 x 10  -8 cc. 
were taken as the intranasal titre. 
:Mice used  in  these  experiments were  the  Swiss  strain  selectively bred  for 
susceptibility to certain central nervous system viruses (1).  When tested with 
St. Louis virus they were consistent and highly uniform in their reactions.  When 
vaccinated  with  virulent  virus  given  subcutaneously  or  intraperitoneally,  all 
animals remained well.  Consequently, their subsequent immunity was attributed 
entirely to the direct effect of the vaccine upon each individual with no disturbing 
possibility that part of the immunity of the batch might be the result merely of a 
weeding out of the susceptible individuals through the lethal effect of the vaccine. 
EXPEI~IMI~.NTS 
Amoun~ of Immunity Developed.  Time of Appearance and Duration 
of Immunity.--Susceptible mice injected subcutaneously with virulent 
virus develop an immunity against both intracerebral  and intranasal 
test inoculations.  This immunity appears in about 4  days, is active 
against  105 intracerebral  and  10' intranasal test doses within  1 week, 
endures for 8 weeks at this approximate level, and disappears in 12 to 
24 weeks.  The following protocol illustrates  some of these findings 
(Table  I). 
Experiment /.--Mice were given 0.5  cc.  of virus  diluted  1 to  1,000 subcu- 
taneously in the groin.  At 1,  7,  14,  20,  and 24 weeks batches were tested for 
intracerebral and intranasal immunity, together with control unvaccinated mice 
of the same age.  Table I  shows that the intracerebral immunity was active in 
1 week against 10  ~  lethal doses, in 7 weeks against l0 s, in 14 weeks against 102, and 
that at 20 and 24 weeks the immunity had practically disappeared.  Similarly 
the intranasal immunity was active in 1 week and at 7 weeks against at least 10  ~ 
doses, in 14 weeks against 10 doses, and at 20 and 24 weeks was negligible. 
Similar  experiments  have  given  comparable  results.  Some  nasal 
immunity was detected as early as 4 days following vaccination. 
Amount  of  Virulent  Virus Required for Immunlzation.--A  subcu- 
taneous injection of at least 500  intracerebral  lethal doses of,virus is 
required to immunize a mouse successfully (Table II).l 
x Cox and Olitsky (J. Exp. Meal., 1936, 63, 745) found that approximately this 
same amount of virulent equine encephalomyelitis virus is necessary to immunize a 
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Experiment 2.--A single subcutaneous injection of 1.5 cc. of mouse brain virus 
diluted from 10  -8 to 10  -7 was given to batches of Swiss mice.  The 10  -7 dilution 
contained approximately 50 intracerebral lethal doses, the 10  -3 dilution, 500,000 
doses.  3 weeks later part of the vaccinated mice,  together with unvaccinated 
controls, were given test virus intracerebrsUy and part intranasaUy.  The smallest 
intracerebral dose, 10  -s, used in the test contained 100 lethal doses, the smallest 
intranasal dose, 10  -4, contained not more than one nasal lethal dose as determined 
by many titrations.  The test was therefore sufficiently sensitive to detect a small 
amount of immunity.  Table II shows that vaccine containing 50 intracerebral 
lethal doses  conferred no immunity, but  that  vaccine containing 500 or more 
units did induce the characteristic high immunity. 
TABLE  II 
Amount of St. Louis Encephalitis Virus Required to Immunize Mice 
Intracerebral test  Intranasal test 
Immunizing dose  Dilution of virus  Dilution of virus 
Number ofintra- 
cerebral lethal doses 
10s  10-4 
None 
5O 
5OO 
5,000 
50,000 
500,000 
1o-4  10-5 
4,* 5, 5  6, 7, 7 
4, 5, 7  5, 5, 6 
S, S, S  S, S, S 
6, S, S  S, S, S 
S, S, S  S, S, S 
S, S, S  S, S, S 
7, 8, 8 
7, 8, S 
9, S, S 
S, S, S 
S, S, S 
S, S, S 
9, 9, 10 
9, S, S 
6, S, S 
S, S, S 
S, S, S 
S, S, S 
* Day of death of mouse following injection. 
S ffi mouse remained well.  Discarded after 30 days. 
Additional  experiments  gave  comparable  results.  Moreover,  not 
only fresh mouse brain virus but virus maintained under other condi- 
tions  behaved  in  a  similar  manner.  For  example,  virus  grown  in 
mouse  embryo brain  plus  10 per  cent  serum-Tyrode culture in  our 
laboratory titrated 10  -6.  This culture virus diluted to 10 -3 to contain 
1,000 intracerebral lethal doses immunized mice against  the virulent 
mouse brain virus.  Greater dilutions, however, containing less than 
1,000 doses,  did not protect.  Again,  brain  virus kept in the frozen 
and dried state gradually decreased in titre until at 12 months, certain 
samples  contained no virulent virus,  others  about  500  intracerebral 
lethal  doses  per 0.03  cc.  tested,  and  still  others,  about  1,000  lethal 
doses.  The immunizing potency of these preparations was tested in 
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in  the first instance  1,000  intracerebral lethal  doses,  in  the second 
instance 500 doses, and in the third instance non-virulent virus.  The 
first preparations immunized the mice well, the second preparations 
gave both positive and negative results, while the third preparations, 
containing no virulent virus, failed to immunize. 
Multiple doses of virulent virus gave no more prompt, no greater, 
nor more enduring immunity than  a  single  dose  containing about 
10,000  intracerebral lethal doses. 
Having found that a single subcutaneous or intraperitoneal injection 
of 1,000  intracerebral lethal doses of virus into susceptible mice im- 
munized them regularly after 4 to 7 days against 10  e intracerebral or 
108 intranasal  doses and that  this immunity persisted 8  weeks and 
finally disappeared at about 20 weeks, we undertook further analyses 
of this immune state and of the immunizing process concerned.  Our 
technique was guided by the view expressed recently by Goodpasture 
that in the voluminous literature on the subject of immunity there is a 
great  deal  about  phagocytosis  and  antibodies  and  complement in 
general, but no scientific explanation of an acquired resistance to any 
infectious agent, due mainly, perhaps, to a  lack of knowledge of the 
pathogenesis of the natural disease (3).  Consequently we paid special 
attention to the question of pathogenesis of infection in the immune 
mouse as compared to pathogenesis of infection in the normal mouse. 
Pathogenesis of Infection in Immune Mice.--The outstanding finding 
to  date in  these  experiments has  been  that  virus  given nasally or 
directly into the brain of immunes does not gain a foothold in the brain 
tissue. 
Experiment 3.--Forty susceptible mice were each given subcutaneously 0.5 co. 
of fresh mouse brain virus diluted 1 to 1,000.  12 days later each received 0.03 co. 
of fresh virus diluted 1 to 100 into the intact nasal orifices.  Five unvaccinated 
mice were similarly inoculated.  1, 2, 3, 4, 6, 8, 10, 15, 25, 35, and 45 days after 
the test inoculation~ three mice were sacrificed,--one for sections of the brain 
and two for testing for the presence of virus in the olfactory bulbs and in the 
brain.  The remaining seven mice were observed for 30 days. 
The  unvaccinated  mice  receiving  the  nasal  instillation  of  virus 
were  dead  by  the  8th  day;  the  seven  vaccinated mice inoculated 
intranasally and set aside for observation remained well, indicating 
that the batch of forty test animals were immunized against a  nasal 116  r~rUNl~  AFTER ENCEPHALITIS VIRUS VACCINATION 
dose fatal to  100 per cent of non-vaccinated animals.  None of the 
twenty-two animals sacrificed and  tested for  the presence of virus 
gave  positive  results  and  none  of  the  eleven examined for  lesions 
showed anything abnormal in the olfactory bulbs or brain.  Appar- 
ently the virus instilled intranasally into immunized mice did not reach 
olfactory bulbs or brain in detectable amounts. 
Finally, animals similarly immunized and given a test intracerebral 
injection of at least  1,000  lethal doses of virus disposed of the virus 
within 4 days and showed lesions related mainly to the puncture wound 
of the hypodermic needle used for the test injection. 
The pathogenesis of infection in immune mice following nasal or 
intracerebral  injection  of  virus  differs  sharply,  then,  from  that  in 
non-immune mice.  In the immune mouse the test virus fails to sur- 
vive in the brain; in the non-immune mouse it reaches the olfactory 
bulbs  within  a  few  hours  following nasal  instillation,  spreads  and 
increases  rapidly,  overwhelming the  mouse  (1).  These  differences 
appear to be due directly to conditions in the brain tissue or associated 
fluids. 
Lack  of Antiviral  Properties in  Blood Serum  of Immune  Mice.- 
The fluids of immune mice, of which blood  serum is  probably  the 
most representative, may theoretically act directly against the virus 
which has reached its tissue of predilection, namely, the  brain  and 
cord, or in some sort of brain tissue combination, or again they may 
be entirely inert.  The first possibility found no support  in  a  large 
series of tests  in  which blood serum from immune mice vaccinated 
as  above, when  combined with virus and injected directly into the 
brain of susceptible mice, in no way altered the pathogenesis of the 
resulting infection.  The  serum from  immune  animals  neither has- 
tened  destruction  nor  reduced  titre  of  the  virus.  The  following 
protocol illustrates the equally high titre of virus mixed with sera or 
with optimum broth diluent (Table III). 
Experiment 4.--Susceptible mice were divided into two batches.  One received 
an immunizing  dose of fresh mouse brain virus, 0.5 ce. of 1 to 1,000 dilution intra- 
peritoneaUy; the other remained untreated as controls.  After 1 week, part of the 
vaccinated animals were tested for immunity and part were bled for serum for a 
neutralization test.  Equal parts of serum were mixed  with equal parts of mouse 
brain virus in various dilutions in broth.  The mixtures were incubated for 2 hours LESLIE  T.  WEBSTER  117 
at 37°C., left standing for 2 hours at 23nc., and finally, each dilution was injected 
in 0.03 cc. amounts intracerebrally into four Swiss mice.  Virus was also mixed 
with serum from unvaccinated mice and tested in a similar manner. 
Table III shows that the virus was as active when mixed with serum 
from  immune  mice  as  when  mixed  with  serum  from  unvaccinated 
mice or with broth alone. 
Tests for antiviral  substances in  the sera of animals vaccinated as 
above have been made throughout the 10 to 20 week span of immunity 
(4).  During the 4 to 8 week period, when the immunity of the mice 
TABLE  III 
Absence of Neutralizing Antibodies in Sera of Immune Mice Following Vaccination 
~th St. Louis Encephalitis Virus 
Virus diluted with 
Broth 
Serum, normal mouse 
Serum, vaccinated mouse (1 wk.) 
Mice injected with 0.03 ec.  mixtures of serum plus 
virus diluted 
10-5 
5,* 5, 5, 5, 5 
5, 5, 5, 6 
5, 5, 5, 6 
10-8 
5, 5, 5, 7, 7, S 
5, 6, 6, S 
6, 6, 9, S 
10-7 
11, S, S, S, S 
7,  S, S, S 
Immunity of Mice from Which Test Sera Were Obtained 
Mice injected with 0.03 cc. virus in dilutions 
Mice 
104  10-4  10 s  10-7  lO-S I 
Normal mice 
Vaccinated mice 
(i  wk.) 
--  --  5,  5,  5,  6 
S, S, S, S  S, S, S, S  S, S, S, S 
10"-8 
5, 6, 6, S  S, S, S, S 
* Footnotes same as in Table I. 
to a  test intracerebral  or intranasal  injection of virus was high,  anti- 
viral activity of their sera was not detected; subsequently, however, 
as the immunity of the mice decreased and finally disappeared,  anti- 
viral activity of their sera appeared and increased progressively.  In 
short, not only is antiviral activity of the serum undetectable during 
the  period  of  maximum  immunity  of  the  animal,  but  it  becomes 
detectable when the active immunity disappears. 
Although  sera  from  immune  mice  do  not  act  against  the  virus 
under  the  above  somewhat  artificial  conditions,  it  is  possible  that 
they may be effective under more natural  conditions;  this has  been 118  IMM'U~ITY  AFTER  ENCEPHALITIS  VIRUS  VACCINATION 
difficult to test.  If virus is injected intravenously into immune and 
non-immune animals, it disappears  so promptly that no differences 
can  be  detected.  Virus  injected  intraperitoneaUy,  however,  into 
immunes and non-immunes appears in the circulating blood in slightly 
higher titre and for a slightly longer interval in non-immunes than in 
immunes.  Whether this small difference is attributable to blood or 
tissues of immune mice is not clear. 
Experiment 5.--Fifteen mice were vaccinated with 0.5 cc. of a 10  -3 dilution of 
virus given subcutaneously.  Fifteen similar mice were left untreated as controls. 
1 week later, when the vaccinated mice were known to be immune, they, together 
with the controls, were given 0.5 cc. of a 0.5  ×  10  -2 dilution of virus intraperi- 
toneally.  At frequent intervals thereafter, vaccinated and  control mice were 
bled from the heart.  Undiluted blood and blood diluted  10  -1 and 10  -2  were 
injected in 0.03 cc. amounts intracerebrally into two Swiss mice to titrate the 
amount of virus present. 
The virus content of the blood of immune and non-immune mice is shown in 
Table  IV.  Following the  intraperitoneal injection of  about  2,000,000 intra- 
cerebral doses of virus, the blood of both  immunes and non-immunes showed 
about 3,000 doses per cc. within 20 to 30 minutes.  This quantity was recovered 
at intervals during a period of 3 hours and 40 minutes from non-immunes; from 
immunes the quantity dropped progressively to less than 30 doses per cc.  (or 
1 per 0.03 cc. which was the limit of sensitivity of the test) at 5 hours.  None  was 
recovered from immunes thereafter, although the non-immunes  showed  300 doses 
at 5 hours and 30 at 6 hours. 
A search for indirect evidence of activity of serum upon the virus 
in the animal was made by means of endothelial blockade and splen- 
ectomy respectively.  Trypan  blue was injected  intravenously into 
susceptible mice in various doses ranging from a  toxic to  a  barely 
coloring level.  At different periods thereafter, from 4 to 24 hours, the 
mice were vaccinated and tested 3 weeks later for their immunity to 
an intracerebral injection.  According to theory, the dye, by blocking 
the endothelial cells' phagocytic activity, interrupts the development 
of antibody formation.  In these tests, however, despite the injection 
of dye, the  animal developed the usual high grade of intracerebral 
immunity.  Similarly,  batches  of  animals  were  splenectomized  24 
hours before vaccination and 1, 2, and 3 days following vaccination. 
3 weeks later their immunity to an intracerebral injection was tested. 
Again the procedure of splenectomy, calculated to interrupt antibody LESLIE  T.  WEBSTER  119 
formation, did not disturb the development of the standard high level 
of intracerebral immunity. 
At present evidence indicates that the essential difference between 
the immune and non-immune mouse rests in the changed condition of 
TABLE  IV 
Titre of St. Louis Virus in Blood of Vaccinated  and Unvaccinated  Mice Following 
Intraperltoneal Injection 
Time after intmperi- 
toneal injection of 
vires 
10 rain. 
18  " 
24  " 
28  " 
50  " 
50  " 
lhr.  45 mln. 
1  "  ,52  " 
3 hrs. 38  " 
3  "  41  " 
5  " 
5  " 
6  u 
6  " 
7  " 
25  " 
25  " 
30  " 
30  " 
72  " 
72  " 
Source of blood 
tested 
Vaccinated 
Unvaccinated 
Vaccinated 
Unvaccinated 
Vaccinated 
Unvaccinated 
Vaccinated 
Unvaccinated 
Vaccinated 
Unvaccinated 
Vaccinated 
Unvaccinated 
Vaccinated 
Unvaccinated 
Vaccinated 
Unvaccinated 
Vaccinated 
Unvaccinated 
Vaccinated 
Unvaccinated 
Vaccinated 
Unvaccinated 
Vaccinated 
Unvaccinated 
Fate of mice injected with 0.03 cc. 
blood in dilutions 
Undilute 
6,* 6 
6,6 
6,6 
4, 4 
8, 8 
6, 6 
8 
6,6 
6, 8 
6, 8 
IG -I 
6, 6 
6,9 
8, 9 
8 
6,6 
6, 8 
13 
6, 8 
10 
6, 13 
8 
9, 6 
6, 6 
6 
Titre of virus in 
blood 
Lethal intracerebral 
doses per cc. 
330 
3,300 
3,300 
330 
3,300+ 
33 
3,300 
33+ 
3,300 
Less than 33 
330 
Less than 33 
33 
Less than 33 
cc  c*  *r 
*c  ct  aE 
*l  Li  cc 
4e  ~e  ¢* 
the brain tissue itself, the tissue to which the virus has a special pre- 
dilection. 
Fate of Virus Employed for Vaccine.--The question of how the brain 
tissue becomes altered is being investigated.  Does the virus in the 
vaccine circulate in the blood,  penetrate  the  brain  capillaries, and 
come into intimate contact with brain cells,  or does it localize else- 120  ImamlTY  A~TER  ENCEPHALITIS  VIRUS  VACCINATION 
where and produce an immunizing substance which then reaches brain 
tissue through the circulation?  Previous tests (1) showed that virus 
injected as a vaccine subcutaneously or intraperitoneally was present 
within 10 minutes in the blood stream in large amounts but that rarely 
after 1 and never after 5 days was it found in blood or organs except 
the spleen.  Nioreover, the mice remained well and showed no brain 
lesions.  Since mice invariably contract a fatal encephalitis if as little 
as 1/1000 cc. of virus-containing blood is injected directly into their 
brain, or if it is provided access to brain cells through trauma following 
a sterile intracerebral needle puncture (1), it is unlikely that the brain 
cells of vaccinated mice were exposed to the virus in the blood. 
Persistence  of Virus in the Spleen.--Following  disappearance from 
blood and organs, virus remains in the spleen and increases somewhat 
in titre (1).  Moreover, it can be recovered, although with increasing 
irregularity, up  to  but  not later  than  34  days  following injection. 
Throughout this time the immunity of the mouse is at a maximum; 
shortly afterwards, however, it commences to decline.  There would 
appear to be some relation, therefore, between duration of virus in the 
animal body and duration of immunity.  Further experiments on this 
question are in progress, 
DISCUSSION 
The experiments described above are limited strictly to the immu- 
nity which follows  vaccination with virus by some artificial route. 
Only to this  extent, therefore, may the immunity produced by  St. 
Louis  encephalitis virus be  compared with  experimental immunity 
produced by other human viruses having special or exclusive predilec- 
tion for the central nervous system.  St. Louis virus, in the first place, 
is  a  relatively  powerful  immunizing  agent,  protecting  the  animal 
against a subsequent injection of a large amount of virus directly into 
the  brain.  Thus  the  St.  Louis-immunized  mouse  will  withstand 
100,000 lethal doses given intracerebrally, the Japanese B and rabies- 
immunized mouse about 1,000 lethal doses, whereas the poliomyelitis- 
immunized  monkey  falls  to  withstand  even  one lethal  close with 
regularity.  Secondly,  the  immunity  of  the  St.  Louis-vaccinated 
mouse, like that of the Japanese B and rabies-vaccinated mouse, is not 
permanent.  Immunity to St. Louis virus is maximum for 4 to 6 weeks LESLIE  T.  WEBSTER  121 
and disappears by the 10th to 20th week; immunity to rabies is maxi- 
mum for about 6 months and disappears after 12 months.  Finally, the 
duration of immunity of the St. Louis-immunized mouse may have 
some connection with the persistence of virus in the  tissue.  This 
possible relationship is being studied further. 
These studies also bear upon the question of whether immunity to 
this group of viruses is humoral or tissue in nature.  Recent English 
reviewers of  immunity to  virus  diseases  (5-7)  regard  all  acquired 
specific  immunity as the result of a  corresponding circulating anti- 
body.  This view seems to rest largely on the fact that in many in- 
fections, immunity, whether produced in nature or by artificial means, 
is associated with specific circulating antibody not otherwise present 
and that this antibody acts in one way or another against the specific 
agent. 
Not always does this simple relation hold, however, and notable 
exceptions have recently been studied in the group of central nervous 
system virus infections.  For example, the monkey vaccinated with 
poliomyelitis virus develops neutralizing antibodies but is not regu- 
larly immune (8-10); the same is true for the mouse vaccinated sub- 
cutaneously with  rabies virus  (11).  Conversely, the  mouse vacci- 
nated with St. Louis virus becomes {rnmune but shows no circulating 
neutralizing bodies.  Therefore, these two  sets of contradictions to 
the general theory above require consideration. 
Bedson attempts  to  reconcile the data on antibody without im- 
munity (6) by assuming that the poliomyelitis neutralizing bodies in 
the monkey without immunity are derived from resistant tissues and 
therefore play no part in resistance.  In Sabin and Olitsky's opinion, 
however (10),  there is no evidence that neutralizing antibodies from 
the poliomyelitis-vaccinated, non-~mruune  monkey differ from those 
in the convalescent immune monkey.  A further example not cited 
by Bedson is found in our report of mice vaccinated with rabies virus 
(11).  If  the mouse is  vaccinated subcutaneously it  develops high 
titre neutralizing antibodies but  no immunity; if vaccinated intra- 
peritoneally with the same suspension, it develops neutralizing anti- 
bodies of similar titre plus immunity.  The circulating neutralizing 
antibodies in the non-immune have not been distinguished from those 
in the ~mmune mouse.  Hence, with no reason to believe that anti- 122  IMMUNITY  AFTER  ENCEPttALITIS  VIRUS  VACCINATION 
bodies in non-immunes differ from those in immunes, the fact remains 
that the presence of high titre circulating neutralizing antibodies in 
an animal does not necessarily render it immune. 
With regard to the second contradiction, immunity in the absence 
of  circulating  antibodies,  Bedson  (6)  and  Burnet  (7)  postulate  a 
mechanism of local formation and functioning of undetectable anti- 
bodies,  again without basis  on fact.  Burnet suggests further that 
this postulate might be tested in a nasally induced neurotropic virus 
infection in a host in which infection rate is high but morbidity low. 
Studies on pathogenesis of such an infection have already been re- 
ported (2) with no evidence of local formation or functioning of anti- 
bodies conditioning infection or morbidity.  Rather the initial degree 
of innate resistance of the brain tissue appears to  condition patho- 
genesis throughout.  Hence with no evidence of local formation or 
functioning of circulating antibodies, the fact remains that animals 
may show a high degree of immunity to certain central nervous system 
virus infections in the absence of detectable circulating antibodies. 
The present experiments with St. Louis encephalitis virus in mice 
have special weight in  that they express quantitative relations be- 
tween a  very high degree of immunity and a  negligible amount of 
antibody activity, and over periods of time when both immunity and 
antibodies are  changing.  The  blood and extracted brain  tissue  of 
immune animals fail to protect the brain of susceptibles against one 
lethal dose of virus, while the brain  in the living immune mouse re- 
sists  a  direct injection of 100,000  lethal doses of virus.  Moreover, 
immunity and neutralizing antibody titre vary in opposite directions 
in that antibody is  minimum when immunity is maximum and in- 
creases  as  immunity decreases.  Finally, studies on pathogenesis of 
infection in susceptible mice following nasal or intracerebral inocula- 
tion  of virus show a  prompt spread of virus and lesions in close as- 
sociation with nervous tissue.  In immune mice, however, 1,000  to 
100,000 lethal doses of virus are blocked and destroyed at once, indi- 
cating a highly potent antagonism not found in serum.  This blocking 
of a tissue type of pathogenesis in the immune mouse, together with 
the failure to  detect antibody activity in the sera of immunes, and 
the  quantitative variation  of immunity  and  antibody  titre  in  op- 
posite directions indicate that the immunity of the mouse to St. Louis LESLIE  T.  WEBSTER  123 
virus following vaccination rests largely on the acquired refractory 
state of the brain tissue itself.' 
At the moment, therefore, immunity  in certain of the central nervous 
system virus infections is not explainable in terms of a  circulating 
antibody acting directly against the virus. 
CONCLUSIONS 
1.  Susceptible mice injected subcutaneously or  intraperitoneally 
with 15,000 intracerebral lethal doses of St. Louis encephalitis virus 
develop an immunity in 4 to 7 days to 1,000 to 1,000,000 lethal doses 
given either intracerebrally or intranasally. 
2.  This immunity persists 4 to 6 weeks, then decreases gradually 
and disappears after 8 to 12 weeks. 
3.  More than 1,000 intracerebral doses of virus given as a vaccine 
do not materially increase the amount or duration of the immunity; 
less than 1,000 doses give little or no immunity. 
4.  Test virus injected intracerebrally into immunized mice induces 
few lesions and is rapidly destroyed; instilled intranasally, it rarely 
reaches the olfactory lobes or brain. 
5.  While immunity is maximum, circulating neutralizing antibodies 
are not detectable.  Moreover, the immunity is not affected by endo- 
thelial cell blockade or by splenectomy. 
6.  A few moments after the immunizing virus is given, it can be 
recovered from the blood in relatively high concentration.  After 24 
hours, the blood no longer contains demonstrable virus nor do any 
organs thus far tested except the spleen.  The brain and cord remain 
entirely normal.  The spleen, however, becomes enlarged and harbors 
virus for as long as 30 days. 
2 The immunity of mice to St. Louis encephalitis infection following vaccination 
may or may not be similar to that accompanying convalescence  from the disease. 
The same is  true  of poliomyelitis immunity in  the  Macacus  monkey.  Hence 
analogous  findings  in  the  St.  Louis-vaccinated immune mouse and  the  polio- 
myelitis-convalescent  immune  monkey  are,  at  the  moment,  of  questionable 
significance.  Attention  may merely be directed  to  the  fact that  in  both  the 
vaccinated mouse and convalescent monkey (10, 12), test virus instilled  nasally or 
injected intracerebrally is promptly destroyed in the  absence of detectable anti- 
bodies. 124  IMMUNITY  AFTER ENCEPHALITIS VIRUS VACCINATION 
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